Specac, Ltd has acquired Amax Precision Ltd to enhance its technological capabilities and strengthen its position as a leading global partner in analytical instrumentation.
Information on the Target
Specac, Ltd ("Specac" or the "Group"), a portfolio company of Ampersand Capital Partners, is a prominent leader in the design and manufacture of spectroscopy accessories and sample preparation solutions. The Group recently announced its acquisition of Amax Precision Ltd ("Amax"), a global authority in precision contract manufacturing for analytical instruments. This strategic acquisition aims to enhance Specac's technological and manufacturing capabilities.
Amax specializes in high-precision engineering and manufacturing, including advanced assembly and testing services. The synergy between Amax's capabilities and Specac's module-based assembly approach fosters greater vertical integration, thereby enhancing the service suite offered to original equipment manufacturer (OEM) partners worldwide. Together, the newly formed entity operates with over 400 employees across three continents, establishing a significant presence near client production and engineering facilities.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The analytical instrumentation industry in the UK has been experiencing robust growth, driven by advancements in technology and increasing demand for precise measurements across various sectors including life scie
Similar Deals
Gannet BioChem → Laysan Bio
2026
Specac, Ltd
invested in
Amax Precision Ltd
in 2026
in a Other deal